209 related articles for article (PubMed ID: 12738843)
1. Biomedicine. A view from the top--prion diseases from 10,000 feet.
Priola SA; Chesebro B; Caughey B
Science; 2003 May; 300(5621):917-9. PubMed ID: 12738843
[No Abstract] [Full Text] [Related]
2. The role of rafts in the fibrillization and aggregation of prions.
Pinheiro TJ
Chem Phys Lipids; 2006 Jun; 141(1-2):66-71. PubMed ID: 16647049
[TBL] [Abstract][Full Text] [Related]
3. Cell biology. Prion toxicity: all sail and no anchor.
Aguzzi A
Science; 2005 Jun; 308(5727):1420-1. PubMed ID: 15933188
[No Abstract] [Full Text] [Related]
4. Truncated PrP(c) in mammalian brain: interspecies variation and location in membrane rafts.
Laffont-Proust I; Hässig R; Haïk S; Simon S; Grassi J; Fonta C; Faucheux BA; Moya KL
Biol Chem; 2006 Mar; 387(3):297-300. PubMed ID: 16542151
[TBL] [Abstract][Full Text] [Related]
5. Spongiform diseases. Waiting for the final experiment.
Enserink M
Science; 2005 Dec; 310(5755):1758. PubMed ID: 16357238
[No Abstract] [Full Text] [Related]
6. The state of the prion.
Weissmann C
Nat Rev Microbiol; 2004 Nov; 2(11):861-71. PubMed ID: 15494743
[TBL] [Abstract][Full Text] [Related]
7. Games played by rogue proteins in prion disorders and Alzheimer's disease.
Aguzzi A; Haass C
Science; 2003 Oct; 302(5646):814-8. PubMed ID: 14593165
[TBL] [Abstract][Full Text] [Related]
8. Prions: proof of proteinaceous nature but problems with population polymorphisms.
Griffiths PD
Rev Med Virol; 2004; 14(6):341-3. PubMed ID: 15495195
[No Abstract] [Full Text] [Related]
9. Structuring the puzzle of prion propagation.
Eghiaian F
Curr Opin Struct Biol; 2005 Dec; 15(6):724-30. PubMed ID: 16263262
[TBL] [Abstract][Full Text] [Related]
10. [Unfolding chaperone as a prion protein relating molecule].
Hachiya NS; Sakasegawa Y; Kaneko K
Rinsho Shinkeigaku; 2003 Nov; 43(11):817-9. PubMed ID: 15152473
[TBL] [Abstract][Full Text] [Related]
11. [Biosynthesis and conversion mechanism of prion protein].
Ishikawa-Sakurai M; Toda H; Kishida H; Hachiya NS; Kuroiwa Y; Kaneko K
Uirusu; 2001 Dec; 51(2):159-62. PubMed ID: 11977756
[No Abstract] [Full Text] [Related]
12. Protein-based PCR for prion diseases?
Telling G
Nat Med; 2001 Jul; 7(7):778-9. PubMed ID: 11433339
[No Abstract] [Full Text] [Related]
13. Photo-induced crosslinking of prion protein oligomers and prions.
Piening N; Weber P; Högen T; Beekes M; Kretzschmar H; Giese A
Amyloid; 2006 Jun; 13(2):67-77. PubMed ID: 16911960
[TBL] [Abstract][Full Text] [Related]
14. The use of transgenic mice in the investigation of transmissible spongiform encephalopathies.
Weissmann C; Fischer M; Raeber A; Büeler H; Sailer A; Shmerling D; Rülicke T; Brandner S; Aguzzi A
Int J Exp Pathol; 1996 Dec; 77(6):283-93. PubMed ID: 9155663
[No Abstract] [Full Text] [Related]
15. [Molecular pathogenesis of spongiform encephalopathy].
Aguzzi A; Maddalena A; Brandner S; Klein M
Pathologica; 1997 Oct; 89(5):481-90. PubMed ID: 9489393
[No Abstract] [Full Text] [Related]
16. Prions and prion diseases.
Pergami P; Poloni TE; Corato M; Camisa B; Ceroni M
Funct Neurol; 1999; 14(4):241-52. PubMed ID: 10713898
[No Abstract] [Full Text] [Related]
17. [Intermediate conformer of prion and dynamics based drug design (DBDD)].
Kazuo K
Tanpakushitsu Kakusan Koso; 2004 May; 49(7 Suppl):1110-2. PubMed ID: 15168541
[No Abstract] [Full Text] [Related]
18. Why are prion diseases precluded by non-mammals?
Ji HF; Zhang HY; Chen LL
Trends Biochem Sci; 2007 May; 32(5):206-8; discussion 208. PubMed ID: 17419063
[No Abstract] [Full Text] [Related]
19. Development of oligomeric prion-protein aggregates in a mouse model of prion disease.
Sasaki K; Minaki H; Iwaki T
J Pathol; 2009 Sep; 219(1):123-30. PubMed ID: 19479969
[TBL] [Abstract][Full Text] [Related]
20. A transmembrane form of the prion protein in neurodegenerative disease.
Hegde RS; Mastrianni JA; Scott MR; DeFea KA; Tremblay P; Torchia M; DeArmond SJ; Prusiner SB; Lingappa VR
Science; 1998 Feb; 279(5352):827-34. PubMed ID: 9452375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
